Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-30 08:41 | English | 402.5 KB | |||
| 2020-07-30 08:25 |
Pharming Group reports financial results for the first half of 2020
|
English | 220.2 KB | ||
| 2020-05-21 11:41 |
Annual General Meeting of Shareholders
|
English | 156.5 KB | ||
| 2020-05-20 08:29 |
Pharming Group announces the nomination of Barbara Yanni and Mark Pykett to the…
|
English | 145.8 KB | ||
| 2020-05-18 08:12 |
Pharming celebrates “hae day :-)”
|
English | 378.7 KB | ||
| 2020-05-14 08:36 |
Pharming Group reports financial results for the first quarter of 2020
|
English | 195.0 KB | ||
| 2020-04-30 08:44 |
Pharming receives European Commission approval for treatment of acute hereditar…
|
English | 141.4 KB | ||
| 2020-04-21 08:13 |
Pharming reports encouraging results from use of RUCONEST® in COVID-19 patients
|
English | 140.7 KB | ||
| 2020-04-08 12:55 |
Pharming Group convenes Annual General Meeting of shareholders
|
English | 149.1 KB | ||
| 2020-04-02 15:01 | English | 5.5 MB | |||
| 2020-03-23 07:20 |
Pharming Enters the Euronext Amsterdam Midkap-index (AMX)
|
English | 110.9 KB | ||
| 2020-03-11 08:16 |
Pharming CFO to step down
|
English | 150.5 KB | ||
| 2020-03-09 08:04 |
Pharming receives FDA approval of new facility for expansion of RUCONEST® produ…
|
English | 137.0 KB | ||
| 2020-03-05 08:35 |
Pharming Group Reports Strong Preliminary (Unaudited) Financial Results for 20…
|
English | 533.5 KB | ||
| 2020-01-21 08:39 |
Pharming receives EMA approval of new facility for expansion of RUCONEST® produ…
|
English | 137.3 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
